A Study of Ridaforolimus (MK-8669) in Combination With Dalotuzumab (MK-0646) Compared to Standard of Care Treatment in Estrogen Receptor Positive Breast Cancer Patients (MK-8669-041 AM3)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Post-Exposure Prophylaxis in Health Care Workers
- Status
- COMPLETED
- Phase
- PHASE4
Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infection
- Status
- COMPLETED
- Phase
- PHASE2
Montelukast and Nasal Epithelial Cell Inflammatory Responses in Asthma and Rhinitis
- Status
- UNKNOWN
- Phase
- N/A
The Relation Between Obesity, Adipose Tissue Content of Fatty Acids and Systemic and Airway Inflammation
- Status
- COMPLETED
- Phase
- N/A
Use of Etoricoxib Compared to Diclofenac in the Perioperative Treatment of Patients After Total Hip Arthroplasty
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Participants Undergoing Hematopoietic Cell Transplants (HCTs) (V212-001)
- Status
- COMPLETED
- Phase
- PHASE3
Niacin (+) Laropiprant (TREDAPTIVE) Re-examination Study (MK-0524A-119)
- Status
- TERMINATED
- Phase
- N/A
Placebo Controlled Study of Preladenant in Participants With Moderate to Severe Parkinson's Disease (P07037)
- Status
- COMPLETED
- Phase
- PHASE3
A Phase I Study of MK-4827 for Treatment of Solid Tumors (MK-4827-005)
- Status
- TERMINATED
- Phase
- PHASE1
Erbitux Study of CPT11, Oxaliplatin, UFToral Targeted Therapy
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Determine the Optimal Dose of Tildrakizumab (SCH 900222/MK-3222) for the Treatment of Moderate-to-severe Chronic Plaque Psoriasis (P05495) (MK-3222-003)
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of Pharmacokinetics, Safety, And Tolerability Of Ertugliflozin (PF-04971729, MK-8835) In Japanese And Western Healthy Participants (MK-8835-041)
- Status
- COMPLETED
- Phase
- PHASE1
The Growth Factor Signature (GFS) as an Intermediate Biomarker of Response for Development of PI3K-Pathway Inhibitors in Patients With Breast Cancer (MK-8669-050)
- Status
- COMPLETED
- Phase
- PHASE1
A Four Week, Open-Label Study of Azithromycin Ophthalmic Solution, 1% (P08641)
- Status
- TERMINATED
- Phase
- PHASE2
Evaluation of Anti-mullerian Hormone Levels as Predictive of IVF Outcomes in Women Over 38 Years Old
- Status
- COMPLETED
- Phase
- N/A
Observational Study of Disease Severity in Participants Diagnosed With Crohn's Disease and Long Term Impact of Treatment Strategies in Participants With Moderate to Severe Crohn's Disease (Protocol P06484)
- Status
- COMPLETED
- Phase
- N/A
A Dose-Range Finding Study in Participants With Type 2 Diabetes (MK-3102-006)
- Status
- COMPLETED
- Phase
- PHASE2
An Active-Controlled Extension Study to NCT01155466 [P04938] and NCT01227265 [P07037] (P06153)
- Status
- TERMINATED
- Phase
- PHASE3
A Study of Pneumococcal Conjugate Vaccine (V114) Compared to a Marketed Vaccine (V114-003)
- Status
- COMPLETED
- Phase
- PHASE2